• Home
  • TZF Polfa S.A
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 8L6
Book a meeting

TZF Polfa S.A

About TZF Polfa S.A

TZF Polfa is a Polish pharmaceutical manufacturer specializing in generic medicines and CMO/CDMO services. The company provides integrated pharmaceutical solutions, from development and analytical support to GMP-compliant commercial manufacturing. Its expertise covers anti-infectives, CNS, cardiovascular, diabetology, dermatology, and highly potent medicines, including advanced aseptic filling and lyophilization technologies for injectable products.

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 8L6
  • Country/Region:
    Poland
  • Founded:
    1823
  • On CPHI since:
    2018
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Contract Manufacturer
Contact info
Show contact info Hide contact info

TZF Polfa S.A Resources (4)

  • TZF POLFA All you need to know

    Brochure TZF POLFA All you need to know

    Discover TZF Polfa — over 200 years of pharmaceutical heritage, combined with comprehensive capabilities and a broad portfolio. Explore what we can offer today, from R&D and manufacturing to end-to-end pharmaceutical solutions.
  • Polfa in a nutshell

    Brochure Polfa in a nutshell

    The history of TZF Polfa is the history of Polish pharmacy. For over 200 years, we have been contributing to Poland's medicine security, evolving from one of...
  • Center for the Development and Production of Highly Potent Drugs

    Video Center for the Development and Production of Highly Potent Drugs

    The Center for Development and Production of Highly Potent Drugs is one of the most advanced injectable drug manufacturing facilities in Europe. This technologically advanced plant fully meets the growing global demand for injectable medicines in various pharmaceutical forms.

    The facility covers over 12,000 m², including 3,000 m² of cleanroom areas, and has been designed according to the latest GMP requirements.

    At the heart of the Center there are two modern production lines – ONCO and COMBO – that allow the manufacture of drugs across different activity classes (including highly potent) in multiple dosage forms and packaging configurations.

    2026-10-01
  • Watch our story

    Video Watch our story

    Discover our story — from over 200 years of pharmaceutical heritage to caring for future generations.

    2026-10-01